(Q37826637)

23 August 2017

1 reference

title

Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings (English)

1 reference

23 August 2017

4

0 references

author name string

Susanne Graef

series ordinal

1

1 reference

23 August 2017

Peter Schönknecht

series ordinal

2

1 reference

23 August 2017

Osama Sabri

series ordinal

3

1 reference

23 August 2017

publication date

8 January 2011

1 reference

23 August 2017

1 reference

23 August 2017

volume

215

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

205-229

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-010-2153-8

23 August 2017

exact match

0 references

cites work

Nicotinic mechanisms of memory: effects of acute local DHbetaE and MLA infusions in the basolateral amygdala

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Arousal, anxiety, and performance: a reexamination of the Inverted-U hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cognitive deficits in depression: possible implications for functional neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Caffeine effects on resting-state arousal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Scopolamine degrades spatial working memory but spares spatial reference memory: dissimilarity of anticholinergic effect and restriction of distal visual cues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Specific contributions of the basal forebrain corticopetal cholinergic system to electroencephalographic activity and sleep/waking behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Ventral hippocampal alpha 7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

An investigation of the effects of benzodiazepine receptor ligands and of scopolamine on conceptual priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Muscarinic acetylcholine receptor subtype mRNA expression and ligand binding in the aged rat forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

AF150(S): a new functionally selective M1 agonist improves cognitive performance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Psychiatric comorbidity of smoking and nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Mecamylamine blocks enhancement of reference memory but not working memory produced by post-training injection of nicotine in rats tested on the radial arm maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Selection for differences in avoidance learning: the Syracuse strains differ in anxiety, not learning ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Testing the NMDA, long-term potentiation, and cholinergic hypotheses of spatial learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Fear conditioning and latent inhibition in mice lacking the high affinity subclass of nicotinic acetylcholine receptors in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Human alpha oscillations in wakefulness, drowsiness period, and REM sleep: different electroencephalographic phenomena within the alpha band

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Characterizing cognition in ADHD: beyond executive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Muscarinic receptors--characterization, coupling and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Frontal cortical alpha7 and alpha4beta2 nicotinic acetylcholine receptors in working and reference memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

The neural basis of interindividual variability in inhibitory efficiency after sleep deprivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Preserved learning and retention of pattern-analyzing skill in amnesia: dissociation of knowing how and knowing that

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Power and coherent oscillations distinguish REM sleep, stage 1 and wakefulness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Antero-posterior EEG changes during the wakefulness-sleep transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

The influence of caffeine on human EEG under resting conditions and during mental loads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of tobacco smoking on the topographic EEG II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Scopolamine and sustained retrieval from semantic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Scopolamine model of dementia: electroencephalogram findings and cognitive performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Selective inactivation of muscarinic receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Central cholinergic systems and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

The early acquisition of two-way (shuttle-box) avoidance as an anxiety-mediated behavior: psychopharmacological validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Neurobiological mechanisms by which nicotine mediates different types of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effect of subcutaneous nicotine injections of EEG alpha frequency in non-smokers: a placebo-controlled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Gating of nicotinic ACh receptors; new insights into structural transitions triggered by agonist binding that induce channel opening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Studies on human memory: The interactions of diazepam, scopolamine, and physostigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of smoking/nicotine on anxiety, heart rate, and lateralization of EEG during a stressful movie.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Smoking, smoking cessation, and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotine acts in the anterior cingulate, but not dorsal or ventral hippocampus, to reverse ethanol-induced learning impairments in the plus-maze discriminative avoidance task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Attentional effects of nicotinic agonists in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

EEG-vigilance differences between patients with borderline personality disorder, patients with obsessive-compulsive disorder and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Mania and attention-deficit/hyperactivity disorder: common symptomatology, common pathophysiology and common treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Deficits of the cholinergic system in early AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Muscarinic receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Activation of cerebral function by CS-932, a functionally selective M1 partial agonist: neurochemical characterization and pharmacological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Suppression of neocortical high-voltage spindles by nicotinic acetylcholine and 5-HT2 receptor stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

A cholinergic-adrenergic hypothesis of mania and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Association between cigarette smoking and anxiety disorders during adolescence and early adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Relationship of electroencephalographic and cardiovascular changes to plasma nicotine levels in tobacco smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Differential effects of MDMA and scopolamine on working versus reference memory in the radial arm maze task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Physostigmine and cognition in schizotypal personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Acute nicotine administration in Alzheimer's disease: an exploratory EEG study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Concurrent blockade of beta-adrenergic and muscarinic receptors disrupts working memory but not reference memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of scopolamine on matching to sample paradigm and related tests in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cognitive mechanisms of nicotine on visual attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Beta2-containing nicotinic receptors contribute to the organization of sleep and regulate putative micro-arousals in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Acute and Chronic Nicotinic Interactions with Dopamine Systems and Working Memory Performancea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Working memory performance and cholinergic effects in the ventral tegmental area and substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

What can preservation of autobiographic memory after muscarinic blockade tell us about the scopolamine model of dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Impaired sustained attention and executive dysfunction: bipolar disorder versus depression-specific markers of affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cholinergic modulation of midbrain dopaminergic systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cognitive neuroscience and the study of memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Dose effects of triazolam and scopolamine on metamemory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Symposium: Cognitive processes and sleep disturbances: Sleep/wake patterns in Alzheimer's disease: relationships with cognition and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

The effects of acute scopolamine in geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Neurochemical dissociation of memory systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Dorsal hippocampal alpha7 and alpha4beta2 nicotinic receptors and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Uncovering the neural signature of lapsing attention: electrophysiological signals predict errors up to 20 s before they occur.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Brain-selective stimulation of nicotinic receptors by TC-1734 enhances ACh transmission from frontoparietal cortex and memory in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Scopolamine impairs performance of a place and cue task in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Scopolamine impairs both working and reference memory in rats: a replication and extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

EEG-vigilance and BOLD effect during simultaneous EEG/fMRI measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Sleeping brain, learning brain. The role of sleep for memory systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effect of nicotine and nicotinic receptors on anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of mecamylamine on spontaneous EEG and performance in smokers and non-smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

The effects of cigarette smoking on pain and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotine improves memory in an object recognition task in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Desensitization of neuronal nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Combined blockade of cholinergic receptors shifts the brain from stimulus encoding to memory consolidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Impaired off-line consolidation of motor memories after combined blockade of cholinergic receptors during REM sleep-rich sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: a novel use of the odour span task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotine improves memory for delayed intentions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Acetylcholine receptors in dementia and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cholinergic drugs affect novel object recognition in rats: relation with hippocampal EEG?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of scopolamine (0.25-0.75 mg i.m.) on the quantitative EEG and the neuropsychological status of healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

The diversity of neuronal nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cognitive, social, and physiological determinants of emotional state.

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

21 January 2018

12 December 2020

Cortico-Basal Ganglia reward network: microcircuitry

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Scopolamine impairs human recognition memory: data and modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential, and verbal memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Clinical and quantitative EEG studies of mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Muscarinic antagonists are anxiogenic in rats tested in the black-white box.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Enhancing effects of nicotine and impairing effects of scopolamine on distinct aspects of performance in computerized attention and working memory tasks in marmoset monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

(R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Antidepressant effects of nicotine in an animal model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Daily processes in stress and smoking: effects of negative events, nicotine dependence, and gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Spatial organization of EEG activity from alertness to sleep stage 2 in old and younger subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Effects of 42 hr of total sleep deprivation on component processes of verbal working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Quantitative assessment of dynamic electroencephalogram (EEG) organization as a tool for subtyping depressive syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

EEG correlates in the spectrum of cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

EEG markers of future cognitive performance in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Adenosine A(1) and A(2A) receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

What happens to anxiety levels on giving up smoking?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Differential effects of scopolamine on working and reference memory of rats in the radial maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Mecamylamine reversal by nicotine and by a partial alpha7 nicotinic acetylcholine receptor agonist (GTS-21) in rabbits tested with delay eyeblink classical conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cholinergic systems in mammalian brain and spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

The relation of strength of stimulus to rapidity of habit-formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cholinergic interneuron characteristics and nicotinic properties in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Cerebral states during sleep, as studied by human brain potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Ist manisches Verhalten ein autoregulatorischer Versuch zur Vigilanzstabilisierung?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2153-8

Preclinical Characterization of A-582941: A Novel α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition-Enhancing Properties

21 January 2018

1 reference

12 December 2020

Smoking behaviors across anxiety disorders

1 reference

12 December 2020

The relationship between depression and cognition

1 reference

12 December 2020

Electroencephalographic effects of intravenous nicotine--a dose-response study

1 reference

12 December 2020

Comparative behavioral and neurochemical activities of cholinergic antagonists in rats

1 reference

12 December 2020

Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory

1 reference

12 December 2020

Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure.

1 reference

12 December 2020

Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety

1 reference

12 December 2020

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.

1 reference

12 December 2020

Antidepressant pharmacotherapy helps some cigarette smokers more than others

1 reference

12 December 2020

Effects of nicotine on cortical high voltage spindles in rats

1 reference

12 December 2020

Decreased level of EEG-vigilance in acute mania as a possible predictor for a rapid effect of methylphenidate: a case study.

1 reference

12 December 2020

The impact of smoking on panic disorder: an initial investigation of a pathoplastic relationship

1 reference

12 December 2020

Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice.

1 reference

12 December 2020

The clinical and theoretical importance of EEG rhythms corresponding to states of lowered vigilance

1 reference

12 December 2020

Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse

1 reference

12 December 2020

The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology

1 reference

12 December 2020

Effects of nicotine on neocortical electrical activity in rats

1 reference

12 December 2020

Processing efficiency and sustained attention in bipolar disorder

1 reference

12 December 2020

The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors.

1 reference

12 December 2020

Animal models of 'anxiety': where next?

1 reference

12 December 2020

Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium.

1 reference

12 December 2020

Perceptual span in schizophrenia and affective disorders.

1 reference

12 December 2020

EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure, and dependence.

1 reference

12 December 2020

Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers

1 reference

12 December 2020

AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.

1 reference

12 December 2020

Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory

1 reference

12 December 2020

Altered anxiety-related responses in mutant mice lacking the beta4 subunit of the nicotinic receptor.

1 reference

12 December 2020

Cholinergic receptor blockade in the rat impairs locale but not taxon strategies for place navigation in a swimming pool

1 reference

12 December 2020

Evaluation of muscarinic and nicotinic receptor antagonists on attention and working memory

1 reference

12 December 2020

Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test

1 reference

12 December 2020

Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic1 receptors.

1 reference

12 December 2020

1 reference

12 December 2020

Beneficial effects of FKS-508 (AF102B), a selective M1 agonist, on the impaired working memory in AF64A-treated rats.

1 reference

12 December 2020

Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus

1 reference

12 December 2020

RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterization

1 reference

12 December 2020

Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.

1 reference

12 December 2020

The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation

1 reference

12 December 2020

10.1007/S00213-010-2153-8

Identifiers

DOI

1 reference

23 August 2017

1 reference